A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EVO / evolocumab

[Related PubMed/MEDLINE]
Total Number of Papers: 3
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EVO  (>> Co-occurring Abbreviation)
Long Form:   evolocumab
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study. ALI, ALI-EVO, CVD, HeFH, LDLC, PCSK9
2017 Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study. ALI, CVD, HeFH, LDLC, PCSK9
2017 Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy. ALI, CVD, FDA, LDL-C, LLT, MTD, MTDLLT